O is not material to Takeda and furthermore they have no obligations to Affymax shareholders to disclose anything. I know everyone wishes it were not so however it is. Please realize that Takeda may never know what happened and be able to keep the drug away from "patients at risk". The number of events was so small that such conclusions are impossible. The only way to answer the question is with a large randomized trial.